Oncolines Biochemical Assay Platforms for Precision Medicine

ResidenceTimer™ Surface Plasmon Resonance (SPR) Platform for Kinetic Binding Experiments

  • Measures target residence time and on- and off-rates
  • Provides a mechanistic rationale for the distinct pharmacological features of one drug candidate compared to another

QuickScout™ Enzyme Activity Assays Across a Kinase Panel

  • Rapid and accurate determination of selectivity with compound screening services
  • Activity can be assessed at physiologically relevant ATP concentration
  • Preincubation service for compounds with slow binding characteristics

Molecular Interactions: Biochemical Assays for Drug-Target Interactions

  • Selection of the best drug candidate for your target via a variety of assays
  • Proof of concept studies, determination of molecular interactions
  • Deconvolution of binding mode, site, and mechanism

Efficient, Convenient, Secure Reporting

  • Primary data and final reports are shared via a secured link

Continuous and High-Throughput Screening Services

  • Turnaround time starts at day of arrival of compounds at Oncolines and ends with transfer of final report and primary data

Finding the Informed Route to the Clinic

Oncolines B.V. boosts the science of your project, helping you to find mechanistic hypotheses for progressing to the clinic in a well-informed manner

  • Available on a fee-for-service basis and collaborations via an integrated Precision Medicine approach.

  • It is our mission to help to bring improved and novel therapies to the right patient population faster.